FDA approves Dupixent for chronic spontaneous urticaria
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with chronic spontaneous urticaria.
Medications
Auto Added by WPeMatico
Read More
New clues as to why drugs are effective for Alzheimer’s disease
A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer’s therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.
Medication-induced sterol disruption: A silent threat to brain development and public health
An editorial published in Brain Medicine raises the alarm about a previously overlooked threat to brain development and public health: the disruption of sterol biosynthesis by common prescription medications.
Over 3 million children died from antimicrobial resistance-related infections in 2022, major study shows
A study presented at ESCMID Global 2025 reveals that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.
Three-year study of tirzepatide shows that most patients only regain 5% or less from their lowest weight
New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that around two-thirds of participants of the SURMOUNT-1 trial had only regained 5% or less of their so-called nadir (or lowest weight) three years after beginning treatment with tirzepatide.
Tavapadon as adjunct to levodopa increases daily ON time in Parkinson’s disease
For patients with Parkinson’s disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time versus placebo, according to a study presented at the annual meeting of the American Academy of Neurology, held from April 5 to 9 in San Diego.
Semaglutide may raise risk for nonarteritic anterior ischemic optic neuropathy in diabetes
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA Ophthalmology.
Study exposes huge levels of untargeted antibiotic prescribing
Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of prognosis and the risk of the infection worsening, according to a new study led by University of Manchester epidemiologists.
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
Can a robot help prepare cancer medication in a hospital pharmacy? That’s what hospital pharmacist Tjerk Geersing investigated in his Ph.D. research. He compared manual and automated preparations in terms of quality, efficiency, and safety. He graduated on 19 March.
Q&A: How can drug repurposing lower drug costs and improve care?
Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that’s expected to continue. Yet, nearly 30% struggle to pay for their prescriptions and more than half of adults are worried about the affordability of their family’s medications, according to polling by KFF.